| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |